About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Prostate Cancer Risk Model to Guide Screening Decisions

by Anjali Aryamvally on January 11, 2018 at 12:53 PM
Font : A-A+

New Prostate Cancer Risk Model to Guide Screening Decisions

A new score for predicting a man's genetic risk of developing aggressive prostate cancer could help guide decisions about who to screen and when, suggests study published in The BMJ. Prostate cancer is the most frequently diagnosed cancer in males in developed countries, with over a million new cases and over 300,000 associated deaths estimated worldwide in 2012.

The problem with PSA

Advertisement


Screening for prostate specific antigen or PSA (a cancer indicator) can lead to early detection and potentially lifesaving treatment. But many guidelines do not endorse universal screening due to concerns about elevated PSA in men without cancer and overtreatment for men who have cancer but might never develop aggressive disease.

Ideally, physicians would identify and screen patients at high risk of developing aggressive prostate cancer at a young age, but a practical clinically useful tool to predict age of onset is not yet available.
Advertisement

So the research team used data from an international study collaboration (the PRACTICAL consortium) to develop and test a genetic tool to predict age of onset of aggressive prostate cancer and to guide decisions of who to screen and at what age.

Study Overview

They analysed over 200,000 gene variants (known as single nucleotide polymorphisms or SNPs) from 31,747 men of European ancestry with and without prostate cancer and identified 54 associated with increased risk of prostate cancer.

These polymorphisms were incorporated into a survival analysis to estimate their effects on age at diagnosis of aggressive prostate cancer in the form of a hazard score.

The final model was then applied to data from an independent clinical trial of 6,411 men to test ("validate") prediction of survival, free from prostate cancer.

In the independent validation, the hazard score was a highly significant predictor of age at diagnosis of aggressive cancer.

Men in the top 2% of the score had an almost three-fold greater relative risk for aggressive prostate cancer compared with men with average risk.

And the researchers say that, as the score is representative of a man's fixed genetic risk, "it can be calculated once, long before onset of prostate cancer, and substantially inform the decision of whether he should undergo screening."

They point to some study limitations, and say they cannot rule out the possibility that other unmeasured factors may have influenced their results. Nevertheless, they say these results "add to existing data as further evidence that genetic features can predict risk of prostate cancer."

They add that the score "is a relatively inexpensive assessment of an individual man's age specific risk and provides objective information on whether a given patient might benefit from PSA screening."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
Toothache
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Prostate Cancer Cancer and Homeopathy Trans-Urethral Resection of the Prostate Prostate Cancer Facts Cancer Facts Cancer Tattoos A Body Art Prostate Cancer: Treatment Options Prostate Specific Antigen [PSA] Nutrition All Men Need 

Recommended Reading
Brachytherapy for Prostate Cancer
Learn about two different types of brachytherapy used for treating prostate cancer. Get information ...
Decipher Test for Prostate Cancer
Decipher test a genomic test for prostate cancer that determines the aggressiveness of the cancer .....
Drugs for Prostate Cancer
Prostate cancer is the main cause of cancer death in men. One of the treatment method includes ......
Medical Management of Prostate Cancer
Prostate cancer is the second most common cancer in men after skin cancer and it is the sixth ......
Nutrition All Men Need
Everyone requires good nutrition, be it man, woman, child or elderly. However, nutrition that men ne...
Prostate Cancer
This cancer affects men over the age of 50 years and screening with rectal examination and PSA can h...
Prostate Cancer: Treatment Options
Treatment options of prostate cancer includes waiting, surgery, radiation, hormone therapy, chemothe...
Prostate Specific Antigen [PSA]
PSA blood test is specific to prostate gland but not necessarily a cancer specific test but is commo...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use